Produkty 1816-85-9

CAS 1816-85-9 występuje w naszej ofercie pod nazwami: 11β-Hydroxytestosterone, 11beta-Hydroxytestosterone, >95% (HPLC). Oferty producentów: Chemat Brand, TRC. Dostępne opakowania: on request, 500mg, 50mg.

11β-Hydroxytestosterone
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
11beta-Hydroxytestosterone, >95% (HPLC)
TRC
  • opakowanie: 500mg, 50mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 1816-85-9) to związek chemiczny o wzorze sumarycznym C19H28O3 i masie molowej 304.4 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: YQDZGFAYWGWSJK-SLMGBJJTSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O3
Masa molowa304.4 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyYQDZGFAYWGWSJK-SLMGBJJTSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 11beta-Hydroxytestosterone, 4-Androstene-11beta,17beta-diol-3-one, (11beta,17beta)-11,17-dihydroxyandrost-4-en-3-one, 11beta,17beta-Dihydroxy-4-androsten-3-one, 11beta,17beta-Dihydroxyandrost-4-en-3-one, 11|A-Hydroxytestosterone, Androst-4-en-3-one, 11,17-dihydroxy-, (11.beta.,17.beta.)-, 11,17-Dihydroxyandrost-4-en-3-one #, YQDZGFAYWGWSJK-SLMGBJJTSA-N, 11beta,17beta-dihydroxyandrost-4-ene-3-one
Izomery (ten sam wzór sumaryczny)
methyl 12-oxo-12-phenyldodecanoate C19H28O3
(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C19H28O3
(3R,5R,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione C19H28O3
(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(1R,3bR,5aS,9aS,9bS)-1-(hydroxymethyl)-1,9a-dimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(6R,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(2R,3bR,5aS,9aS,9bS)-2-hydroxy-1,1,9a-trimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(3S,4R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3
(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one C19H28O3
(1S,3aS,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,5,5a,6,9,9b,10,11-decahydroindeno[4,5-h]isochromen-7-one C19H28O3
(3R,5S,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione C19H28O3
(3S,7S,8R,9S,10R,13S,14S)-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3